175
Views
14
CrossRef citations to date
0
Altmetric
Research Articles

Development and characterization of octreotide-modified curcumin plus docetaxel micelles for potential treatment of non-small-cell lung cancer

, , , , , , , & show all
Pages 1164-1174 | Received 06 Apr 2019, Accepted 19 Jul 2019, Published online: 08 Aug 2019

References

  • Apykhtina OL, Dybkova SM, Sokurenko LM, Chaikovsky YB. 2018. Cytotoxic and genotoxic effects of cadmium sulfide nanoparticles. Exp Oncol. 40:194–199.
  • Chen X, Zhao L, Kang Y, He Z, Xiong F, Ling X, Wu J. 2018. Significant suppression of non-small-cell lung cancer by hydrophobic poly(ester amide) nanoparticles with high docetaxel loading. Front Pharmacol. 9:118.
  • De Souza LR, Muehlmann LA, Matos LC, Simón-Vázquez R, Lacava ZG, De-Paula AM, Mosiniewicz-Szablewska E, Suchocki P, Morais PC, González-Fernández Á, et al. 2015. Antitumor activity and systemic effects of PVM/MA-shelled selol nanocapsules in lung adenocarcinoma-bearing mice. Nanotechnology. 26:505101.
  • Deng YI, Verron E, Rohanizadeh R. 2016. Molecular mechanisms of anti-metastatic activity of curcumin. Anticancer Res. 36:5639–5647.
  • Gu Y, Li J, Li Y, Song L, Li D, Peng L, Wan Y, Hua S. 2016. Nanomicelles loaded with doxorubicin and curcumin for alleviating multidrug resistance in lung cancer. Int J Nanomedicine. 11:5757–5770.
  • Guo JR, Yin L, Chen YQ, Jin XJ, Zhou X, Zhu NN, Liu XQ, Wei HW, Duan LS. 2018. Autologous blood transfusion augments impaired wound healing in diabetic mice by enhancing lncRNA H19 expression via the HIF-1alpha signaling pathway. Cell Commun Signal. 16:84.
  • Hung WY, Chang JH, Cheng Y, Chen CK, Chen JQ, Hua KT, Cheng CW, Hsiao M, Chung CL, Lee WJ, Chien MH. 2018. Leukocyte cell-derived chemotaxin 2 retards non-small cell lung cancer progression through antagonizing MET and EGFR activities. Cell Physiol Biochem. 51:337–355.
  • Jin X, Zhou B, Xue L, San W. 2015. Soluplus(®) micelles as a potential drug delivery system for reversal of resistant tumor. Biomed Pharmacother. 69:388–395.
  • Ju RJ, Cheng L, Qiu X, Liu S, Song XL, Peng XM, Wang T, Li CQ, Li XT. 2018. Hyaluronic acid modified daunorubicin plus honokiol cationic liposomes for the treatment of breast cancer along with the elimination vasculogenic mimicry channels. J Drug Target. 26:793–805.
  • Ju RJ, Li XT, Shi JF, Li XY, Sun MG, Zeng F, Zhou J, Liu L, Zhang CX, Zhao WY, Lu WL. 2014. Liposomes, modified with PTDHIV-1 peptide, containing epirubicin and celecoxib, to target vasculogenic mimicry channels in invasive breast cancer. Biomaterials. 35:7610–7621.
  • Kanou T, Okami J, Tokunaga T, Fujiwara A, Ishida D, Kuno H, Higashiyama M. 2014. Prognosis associated with surgery for non-small cell lung cancer and synchronous brain metastasis. Surg Today. 44:1321–1327.
  • Khoontawad J, Intuyod K, Rucksaken R, Hongsrichan N, Pairojkul C, Pinlaor P, Boonmars T, Wongkham C, Jones A, Plieskatt J, et al. 2018. Discovering proteins for chemoprevention and chemotherapy by curcumin in liver fluke infection-induced bile duct cancer. PLoS One. 13:e0207405.
  • Li N, Zhang CX, Wang XX, Zhang L, Ma X, Zhou J, Ju RJ, Li XY, Zhao WY, Lu WL. 2013. Development of targeting lonidamine liposomes that circumvent drug-resistant cancer by acting on mitochondrial signaling pathways. Biomaterials. 34:3366–3380.
  • Li X, Ma S, Yang P, Sun B, Zhang Y, Sun Y, Hao M, Mou R, Jia Y. 2018. Anticancer effects of curcumin on nude mice bearing lung cancer A549 cell subsets SP and NSP cells. Oncol Lett. 16:6756–6762.
  • Li XT, He ML, Zhou ZY, Jiang Y, Cheng L. 2015. The antitumor activity of PNA modified vinblastine cationic liposomes on Lewis lung tumor cells: in vitro and in vivo evaluation. Int J Pharm. 487:223–233.
  • Li XT, Ju RJ, Li XY, Zeng F, Shi JF, Liu L, Zhang CX, Sun MG, Lou JN, Lu WL. 2014. Multifunctional targeting daunorubicin plus quinacrine liposomes, modified by wheat germ agglutinin and tamoxifen, for treating brain glioma and glioma stem cells. Oncotarget. 5:6497–6511.
  • Liu L, Zhang Y, Wei J, Chen Z, Yu J. 2019. A pilot study of amino acids in unresectable non-small-cell lung cancer patients during chemotherapy: a randomized serial N-of-1 trials design. Nutr Cancer. 71:399–408.
  • Lu S, Zhang Z, Chen M, Li C, Liu L, Li Y. 2017. Silibinin inhibits the migration and invasion of human gastric cancer SGC7901 cells by downregulating MMP-2 and MMP-9 expression via the p38MAPK signaling pathway. Oncol Lett. 14:7577–7582.
  • Luo M, Luo Y, Mao N, Huang G, Teng C, Wang H, Wu J, Liao X, Yang J. 2018. Cancer-associated fibroblasts accelerate malignant progression of non-small cell lung cancer via connexin 43-formed unidirectional gap junctional intercellular communication. Cell Physiol Biochem. 51:315–336.
  • Peeler DJ, Thai SN, Cheng Y, Horner PJ, Sellers DL, Pun SH. 2019. pH-sensitive polymer micelles provide selective and potentiated lytic capacity to venom peptides for effective intracellular delivery. Biomaterials. 192:235–244.
  • Quiros-Gonzalez I, Tomaszewski MR, Aitken SJ, Ansel-Bollepalli L, McDuffus LA, Gill M, Hacker L, Brunker J, Bohndiek SE. 2018. Optoacoustics delineates murine breast cancer models displaying angiogenesis and vascular mimicry. Br J Cancer. 118:1098–1106.
  • Rahdar A, Aliahmad M, Kor AM, Sahoo D. 2019. Probing the reverse micelle environment with a cationic dye by varying oil and water content of micelles. Spectrochim Acta A Mol Biomol Spectrosc. 210:165–170.
  • Song XL, Ju RJ, Xiao Y, Wang X, Liu S, Fu M, Liu JJ, Gu LY, Li XT, Cheng L. 2017. Application of multifunctional targeting epirubicin liposomes in the treatment of non-small-cell lung cancer. Int J Nanomedicine. 12:7433–7451.
  • Tang YT, Huang YY, Li JH, Qin SH, Xu Y, An TX, Liu CC, Wang Q, Zheng L. 2018. Alterations in exosomal miRNA profile upon epithelial-mesenchymal transition in human lung cancer cell lines. BMC Genomics. 19:802.
  • Torre LA, Siegel RL, Jemal A. 2016. Lung cancer statistics. Adv Exp Med Biol. 893:1–19.
  • Varela-Garcia A, Concheiro A, Alvarez-Lorenzo C. 2018. Soluplus micelles for acyclovir ocular delivery: formulation and cornea and sclera permeability. Int J Pharm. 552:39–47.
  • Wang Q, Liu Y, Pu C, Zhang H, Tan X, Gou J, He H, Yin T, Zhang Y, Wang Y, Tang X. 2018. Drug-polymer interaction, pharmacokinetics and antitumor effect of PEG-PLA/taxane derivative TM-2 micelles for intravenous drug delivery. Pharm Res. 35:208.
  • Wang S, Liu X, Huang J, Zhang Y, Sang C, Li T, Yuan J. 2018. Expression of KIAA1456 in lung cancer tissue and its effects on proliferation, migration and invasion of lung cancer cells. Oncol Lett. 16:3791–3795.
  • Wigerup C, Påhlman S, Bexell D. 2016. Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer. Pharmacol Ther. 164:152–169.
  • Winnick A, Sadeghpour S, Otero-Millan J, Chang TP, Kheradmand A. 2018. Errors of upright perception in patients with vestibular migraine. Front Neurol. 9:892.
  • Yu Y, Liu M, Hua L, Qiu M, Zhang W, Wei Y, Gan Y, Feng Z, Shao G, Xiong Q. 2018. Fructose-1,6-bisphosphate aldolase encoded by a core gene of Mycoplasma hyopneumoniae contributes to host cell adhesion. Vet Res. 49:114.
  • Zhu Y, Zhu R, Wang M, Wu B, He X, Qian Y, Wang S. 2016. Anti-metastatic and anti-angiogenic activities of core-shell SiO2@LDH loaded with etoposide in non-small-cell lung cancer. Adv Sci (Weinh). 3:1600229.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.